Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Blasco

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 24, 2009
A method for the determination and hardware validation of biosignal processing parametersM Elena, S Blasco, J M Quero
Revista Clinica Espanola|November 20, 2019
Large biatrial myxoma through an atrial septal defectS Blasco Turrión, P González Pérez, J A Sánchez Brotons
Frontiers in Psychology|January 7, 2021
Gratitude Questionnaire-20 Items (G20): A Cross-Cultural, Psychometric and Crowdsourcing AnalysisGloria Bernabe-Valero, José S Blasco-Magraner, Marianela R García-March
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 24, 2009
IMS: a new technology to develop a telemedicine systemJ D Uceda, M Elena, S Blasco, et al.
Dalton Transactions (Cambridge, England : 2003)|May 6, 2017
Pb<sup>2+</sup> complexes of small-cavity azamacrocyclic ligands: thermodynamic and kinetic studiesA Liberato, A Aguinaco, M P Clares, et al.
International Journal of Cardiology|November 28, 2016
Familial dilated cardiomyopathy: A multidisciplinary entity, from basic screening to novel circulating biomarkersD de Gonzalo-Calvo, M Quezada, O Campuzano, et al.
Molecular Therapy. Nucleic Acids|December 2, 2022
An optimized MNK1b aptamer, apMNKQ2, and its potential use as a therapeutic agent in breast cancerC Pinto-Díez, R Ferreras-Martín, R Carrión-Marchante, et al.
ESMO Real World Data and Digital Oncology|July 1, 2026
First-line osimertinib in advanced <i>EGFR</i>-mutated NSCLC: real-world outcomes, clinicogenomic correlates, and oligoprogression management in a multicenter Spanish cohortG Suay, S Cases-Esteban, P Capdevila, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 11, 2018
Correction to: Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patientsJ Garde-Noguera, P Martin-Martorell, M De Julián, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 26, 2018
Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patientsJ Garde-Noguera, P Martin-Martorell, M De Julián, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 24, 2009
A method for the determination and hardware validation of biosignal processing parametersM Elena, S Blasco, J M Quero
Revista Clinica Espanola|November 20, 2019
Large biatrial myxoma through an atrial septal defectS Blasco Turrión, P González Pérez, J A Sánchez Brotons
Frontiers in Psychology|January 7, 2021
Gratitude Questionnaire-20 Items (G20): A Cross-Cultural, Psychometric and Crowdsourcing AnalysisGloria Bernabe-Valero, José S Blasco-Magraner, Marianela R García-March
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 24, 2009
IMS: a new technology to develop a telemedicine systemJ D Uceda, M Elena, S Blasco, et al.
Dalton Transactions (Cambridge, England : 2003)|May 6, 2017
Pb<sup>2+</sup> complexes of small-cavity azamacrocyclic ligands: thermodynamic and kinetic studiesA Liberato, A Aguinaco, M P Clares, et al.
International Journal of Cardiology|November 28, 2016
Familial dilated cardiomyopathy: A multidisciplinary entity, from basic screening to novel circulating biomarkersD de Gonzalo-Calvo, M Quezada, O Campuzano, et al.
Molecular Therapy. Nucleic Acids|December 2, 2022
An optimized MNK1b aptamer, apMNKQ2, and its potential use as a therapeutic agent in breast cancerC Pinto-Díez, R Ferreras-Martín, R Carrión-Marchante, et al.
ESMO Real World Data and Digital Oncology|July 1, 2026
First-line osimertinib in advanced <i>EGFR</i>-mutated NSCLC: real-world outcomes, clinicogenomic correlates, and oligoprogression management in a multicenter Spanish cohortG Suay, S Cases-Esteban, P Capdevila, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 11, 2018
Correction to: Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patientsJ Garde-Noguera, P Martin-Martorell, M De Julián, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 26, 2018
Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patientsJ Garde-Noguera, P Martin-Martorell, M De Julián, et al.
Pageof 1